| Ms Debra S Cipriani, MS ED PT | |
|
890 Route 35, Cross River, NY 10518 | |
| (914) 763-5941 | |
| (914) 763-5332 |
| Full Name | Ms Debra S Cipriani |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 890 Route 35, Cross River, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487728135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0044011 (New York) | Primary |
| Provider Name | Johanna Lubbe Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1104437516 PECOS PAC ID: 1759701337 Enrollment ID: O20201020003473 |
News Archive
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.
"In the build-up to the London Summit on Family Planning, there have been a lot of opinions expressed on blogs, in mainstream media coverage, in peer-reviewed journals, and even exchanges on the streets and at the water cooler," Gary Darmstadt, head of the Bill & Melinda Gates Foundation's Family Health Division, writes in this post in the foundation's "Impatient Optimists" blog.
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Debra S Cipriani, MS ED PT Po Box 104, Cross River, NY 10518 Ph: (914) 763-5941 | Ms Debra S Cipriani, MS ED PT 890 Route 35, Cross River, NY 10518 Ph: (914) 763-5941 |
News Archive
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.
"In the build-up to the London Summit on Family Planning, there have been a lot of opinions expressed on blogs, in mainstream media coverage, in peer-reviewed journals, and even exchanges on the streets and at the water cooler," Gary Darmstadt, head of the Bill & Melinda Gates Foundation's Family Health Division, writes in this post in the foundation's "Impatient Optimists" blog.
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
› Verified 9 days ago
Michael John Sweeney, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 | |
Johanna Lubbe Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 892 Ny-35, Cross River, NY 10518 Phone: 914-875-9430 | |
Mrs. Anna M Mercer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 | |
Johanna Lubbe, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 892 Route 35, Cross River, NY 10518 Phone: 914-875-9430 Fax: 914-875-9435 | |
Physical Therapy Of Lewisboro Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 | |
Lewisboro Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 |